BioIQ
Latest round
- Series G
Last raised
- Mar 2018
Total raised
- $29M
Investors
- 3
About BioIQ
BioIQ Inc.Founded in 2005, BioIQ Inc. is headquartered in Atlanta, US, and specializes in innovative health testing services. The company was acquired by PrivaPath Diagnostics Limited in November 2021, expanding its reach and capabilities. Justin Bellante founded BioIQ, and under CEO Markus Ollikainen, it has successfully navigated the healthcare landscape.BioIQ, now a LetsGetChecked company, specializes in consumer-centric health testing and immunization services designed to enhance access to healthcare diagnostics and treatment. The company's core offerings include a comprehensive suite of over 100 diagnostic tests that range from at-home testing for various health conditions to telehealth consultations and pharmacy capabilities. These services cater to a diverse clientele, including Fortune 500 companies, government agencies, and over 50 health plans, aiming to address consumer needs for convenient and reliable health insights. BioIQ's products are widely available across the United States, tapping into the growing demand for at-home healthcare solutions that empower individuals to manage their health proactively.Revenue generation for BioIQ is achieved through a mix of direct-to-consumer sales and B2B partnerships, leveraging its innovative healthcare solutions. Clients, which include health plans and corporate partners, can access BioIQ's diagnostic testing services, which are structured around subscription models or contractual agreements tailored to their specific healthcare needs. The company facilitates transactions by offering a flexible pricing structure for its health tests and services, ensuring accessibility for clients while delivering high-quality healthcare solutions. BioIQ's flagship offerings focus on integrating lab testing with telehealth support, creating a seamless experience for end-users.Looking ahead, BioIQ aims to enhance its product lineup with new health testing solutions, although specific release dates have not been disclosed. Geographic expansion is also a priority, with plans to extend services into additional regions within the US in the coming years. The acquisition by PrivaPath Diagnostics Limited will enable the integration of BioIQ’s services with a broader portfolio, ultimately aiming to enhance consumer and partner access to healthcare diagnostics and treatment options.
Who invested in BioIQ
3 investors across 2 rounds
See all investors in BioIQ
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioIQ
Who invested in BioIQ?
BioIQ has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioIQ raised?
BioIQ has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BioIQ last raise money?
BioIQ's most recent round on record is a Series G, in Mar 2018.
What does BioIQ do?
BioIQ is a medical devices & equipment company.
Where is BioIQ headquartered?
BioIQ is headquartered in Atlanta, US.
Which VCs invest in companies like BioIQ?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at BioIQ's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series G
Raising like BioIQ? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.